Forte Biosciences, Inc. - Common Stock, par value $0.001 per share (FBRX)
CUSIP: 34962G109
Q1 2023 13F Holders as of 31 Mar 2023
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 20,563,488
- Total 13F shares
- 3,865,337
- Share change
- +62,355
- Total reported value
- $3,904,404
- Put/Call ratio
- 0.53%
- Price per share
- $1.01
- Number of holders
- 28
- Value change
- +$63,530
- Number of buys
- 8
- Number of sells
- 12
Quarterly Holders Quick Answers
What is CUSIP 34962G109?
CUSIP 34962G109 identifies FBRX - Forte Biosciences, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 34962G109:
Top shareholders of FBRX - Forte Biosciences, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BML Capital Management, LLC |
13F
|
Company |
7.1%
|
1,461,364
|
$1,461,364 | — | 31 Dec 2022 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.1%
|
647,548
|
$647,548 | — | 31 Dec 2022 | |
| Newtyn Management, LLC |
13F
|
Company |
2.7%
|
548,748
|
$548,748 | — | 31 Dec 2022 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
1.3%
|
277,500
|
$278,000 | — | 31 Dec 2022 | |
| BlackRock Finance, Inc. |
13F
|
Company |
1%
|
211,876
|
$211,876 | — | 31 Dec 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.94%
|
192,448
|
$192,000 | — | 31 Dec 2022 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.34%
|
70,891
|
$70,891 | — | 31 Dec 2022 | |
| Old Well Partners, LLC |
13F
|
Company |
0.33%
|
68,600
|
$68,600 | — | 31 Dec 2022 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.33%
|
67,602
|
$68,000 | — | 31 Dec 2022 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.31%
|
62,964
|
$62,964 | — | 31 Dec 2022 | |
| STATE STREET CORP |
13F
|
Company |
0.2%
|
41,664
|
$41,664 | — | 31 Dec 2022 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.18%
|
36,865
|
$36,865 | — | 31 Dec 2022 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.13%
|
26,379
|
$26,379 | — | 31 Dec 2022 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.1%
|
20,333
|
$20,333 | — | 31 Dec 2022 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.07%
|
13,435
|
$13,435 | — | 31 Dec 2022 | |
| Aries Wealth Management |
13F
|
Company |
0.06%
|
13,000
|
$13,000 | — | 31 Dec 2022 | |
| HSBC HOLDINGS PLC |
13F
|
Company |
0.05%
|
10,745
|
$10,530 | — | 31 Dec 2022 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0.04%
|
7,888
|
$7,888 | — | 31 Dec 2022 | |
| FNY Investment Advisers, LLC |
13F
|
Company |
0.04%
|
7,500
|
$7,000 | — | 31 Dec 2022 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.02%
|
4,569
|
$4,569 | — | 31 Dec 2022 | |
| Cutler Group LLC / CA |
13F
|
Company |
0.02%
|
3,987
|
$3,000 | — | 31 Dec 2022 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0.01%
|
1,080
|
$2,000 | — | 31 Dec 2022 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0.01%
|
1,792
|
$1,792 | — | 31 Dec 2022 | |
| UBS Group AG |
13F
|
Company |
0.01%
|
1,715
|
$1,715 | — | 31 Dec 2022 | |
| MORGAN STANLEY |
13F
|
Company |
0.01%
|
1,419
|
$1,419 | — | 31 Dec 2022 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0%
|
453
|
$453 | — | 31 Dec 2022 | |
| LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA |
13F
|
Company |
0%
|
193
|
$193 | — | 31 Dec 2022 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
163
|
$163 | — | 31 Dec 2022 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
126
|
$126 | — | 31 Dec 2022 | |
| TD Waterhouse Canada Inc. |
13F
|
Company |
0%
|
100
|
$104 | — | 31 Dec 2022 | |
| Larson Financial Group LLC |
13F
|
Company |
0%
|
35
|
$35 | — | 31 Dec 2022 | |
| Patricia S. Walker |
3/4/5
|
Director |
—
class O/S missing
|
25,000
|
— | — | 01 Jun 2022 |
Institutional Holders of Forte Biosciences, Inc. - Common Stock, par value $0.001 per share (FBRX) as of Q1 2023
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2023 vs Q4 2022 Across Filers
| Investor | Q4 2022 Shares | Q1 2023 Shares | Share Diff | Share Chg % | Q4 2022 Value $ | Q1 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
An asterisk sign (*) next to the price indicates that the price is likely invalid.